Építés alatt – nem éles oldal
Belépés

What researchers published on Hasnyálmirigyrák

55 847 papers, newest first.

Showing 40 of 55 847

  • Tumor location in the pancreatic body/tail as an independent risk factor for early recurrence after curative resection of pancreatic ductal adenocarcinoma: a single-center retrospective study.Frontiers in oncology
  • Prospective Evidence of Concomitant Pancreatic Ductal Adenocarcinoma Risk Among Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Without Worrisome Features/High-risk Stigmata at Baseline.Annals of surgery
  • A biomimetic desmoplastic pancreatic cancer organoid model reveals macrophage contributions to stiffness-associated chemoresistance.Matrix biology plus
  • Malignant melanoma of unknown primary mimicking pancreatic cancer diagnosed by EUS-guided fine-needle biopsy: NRAS mutation and a rare KIT exon 17 variant.Endoscopic ultrasound
  • ÁttekintésPatient-Derived Organoids in Pancreatic Cancer Pharmacology: From Pharmacotyping Methodology to the AVATAR Phase III Trial and the Pharmacological Frontier.Drug design, development and therapy
  • Targeting SUMOylation in Combination with Agonistic Anti-CD40 Therapy Activates Anti- Tumor Immunity to Control Pancreatic Cancer.Molecular cancer therapeutics
  • ÁttekintésEarly detection and interception in hepato-pancreatic-biliary cancers: endoscopic imaging, liquid biopsy, and emerging molecular biomarkers.Frontiers in oncology
  • ÁttekintésPreoperative Biliary Drainage for Pancreatobiliary Tumor.Journal of Korean medical science
  • EsetismertetésPancreatic ductal adenocarcinoma with atypical biliary obstruction secondary to tension pneumobilia: a case report.Journal of medical case reports
  • ÁttekintésmiR-221 and miR-222 in pancreatic ductal adenocarcinoma: mechanistic evidence, extracellular vesicle communication, biomarker candidates, and therapeutic prospects.Cancer treatment and research communications
  • Reply to the Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.Chirurgia (Bucharest, Romania : 1990)
  • ASO Visual Abstract: Prognostic Impact of the Combined Use of CA19-9 and DUPAN-2 in Initially Unresectable Locally Advanced Pancreatic Adenocarcinoma.Annals of surgical oncology
  • High-Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study.United European gastroenterology journal
  • Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.Chirurgia (Bucharest, Romania : 1990)
  • Inkjet-printed single cell-derived pancreatic cancer organoid for intratumoral heterogeneity quantification.Biofabrication
  • Mesentericoportal Venous Shunting in Surgery for Locally Advanced Pancreatic Tumors: Results of a Standardized Approach for Oncovascular Pancreatic Surgery.Annals of surgical oncology
  • An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer.Molecular therapy. Oncology
  • OSBPL3 promotes pancreatic ductal adenocarcinoma progression through lipid metabolism reprogramming and is targeted by lupenone.European journal of pharmacology
  • ÁttekintésComputational and experimental strategies for functional validation of non-coding variants in pancreatic cancer.Functional & integrative genomics
  • ASO Visual Abstract: CARG Score Predicts Perioperative Chemotherapy Completion in Pancreatic Cancer: Association of Completion with Overall Survival.Annals of surgical oncology
  • Integrating metabolism and immunity: targeting lactate-mediated mechanisms in PDAC.Cancer & metabolism
  • AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
  • Beyond physician perspectives: advancing simultaneous care in pancreatic adenocarcinoma through multidisciplinary and implementation science approaches.The journal of nutrition, health & aging
  • ÁttekintésHepatocellular Carcinoma and Pancreaticobiliary Tumors.Magnetic resonance imaging clinics of North America
  • Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • ACSL5 suppresses pancreatic cancer progression and gemcitabine resistance by regulating n-6 docosapentaenoic acid metabolism.Cell death & disease
  • ÁttekintésTumo​r-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
  • ÁttekintésUnifying functional experimental systems with clinical predictive technologies for personalized care in PDAC.Molecular cancer
  • Áttekintés[Research progress of irreversible electroporation for pancreatic cancer].Zhonghua nei ke za zhi
  • Bioabsorbable spacer-assisted high-dose proton beam therapy for unresectable locally advanced pancreatic cancer of the body or tail: a feasibility and safety study.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • Schisandrin B Suppresses Pancreatic Ductal Adenocarcinoma Through EGFR/AKT/mTOR Signaling and Mitochondrial Dysfunction.International journal of molecular sciences
  • ÁttekintésSynergizing Against RAS: The Evolving Landscape of Targeted Combinations in Pancreatic Cancer.Cancers
  • Activity of Fluoro-Substituted 3,5-Di[(E)-Benzylidene]piperidin-4-Ones with N-Arylsulfonyl Appendages Against KRAS-Mutant Pancreatic Ductal Adenocarcinoma Cells.International journal of molecular sciences
  • ÁttekintésCirculating Tumor DNA Across the Patient Journey in Pancreatic Cancer: From Molecular Profiling to Dynamic Disease Monitoring.Cancers
  • ÁttekintésTreatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer.Cancers
  • Yellow, Red, and Black Lepidium meyenii Preparations Differentially Modulate Doxorubicin Response and Lipid Metabolism-Related Changes in Pancreatic Cancer Cells.Molecules (Basel, Switzerland)
  • Long-Term Outcomes of Anatomical and Biological Borderline Resectable Pancreatic Ductal Adenocarcinoma After Gemcitabine/S-1-Based Neoadjuvant Chemoradiotherapy.Cancers
  • ÁttekintésThe Association Between Asthma and Pancreatic Cancer: A Systematic Review.Cancers
  • OTI1H1-Defined MAGEA3-Directed Immunoreactivity and Survival in Pancreatic Ductal Adenocarcinoma: A Single-Center Study.Journal of clinical medicine
  • Cellularity Improvement of EUS-FNB Specimens for Pancreatic Adenocarcinoma Using a Cell-Capturing Scaffold.Journal of clinical medicine